The Association between Conventional Antidepressants and the Metabolic Syndrome: A Review of the Evidence and Clinical Implications

By McIntyre Roger S.   >  

CNS Drugs, Vol. 24, Iss. 9, 2010-09 ,pp. : 741-753

Adis International

Access to resources Recommend Favorite

Communication between pharmacists and patients receiving antidepressants is poor

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 349, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Safety of Hypericum in Patients with Depression: A Comparison with Conventional Antidepressants

By Stevinson C.   Ernst E.  

CNS Drugs, Vol. 11, Iss. 2, 1999-02 ,pp. : 125-132

Adis International

Access to resources Recommend Favorite

Long-term Effect of Glimepiride and Rosiglitazone on Non-conventional Cardiovascular Risk Factors in Metformin-treated Patients Affected by Metabolic Syndrome: a Randomized, Double-blind Clinical Trial

By Derosa G   Gaddi AV   Ciccarelli L   Fogari E   Ghelfi M   Cicero AFG  

The Journal of International Medical Research, Vol. 33, Iss. 3, 2005-05 ,pp. : 284-294

Field House Publishing

Access to resources Recommend Favorite

Pharmacologic Therapy for Cardiovascular Risk Reduction in Patients with the Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-01 ,pp. : 5025-5038

Bentham Science Publishers

Access to resources Recommend Favorite